MXPA02012879A - Inhibidores de ciclooxigenasa-2 y la prevencion de los efectos secundarios de terapia por radiacion. - Google Patents
Inhibidores de ciclooxigenasa-2 y la prevencion de los efectos secundarios de terapia por radiacion.Info
- Publication number
- MXPA02012879A MXPA02012879A MXPA02012879A MXPA02012879A MXPA02012879A MX PA02012879 A MXPA02012879 A MX PA02012879A MX PA02012879 A MXPA02012879 A MX PA02012879A MX PA02012879 A MXPA02012879 A MX PA02012879A MX PA02012879 A MXPA02012879 A MX PA02012879A
- Authority
- MX
- Mexico
- Prior art keywords
- cox
- side effects
- inhibitors
- prevention
- radiation therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Abstract
Se describe un metodo generalizado para reducir los efectos secundarios deletereos de la radioterapia en sujetos que se someten a radioterapia para el tratamiento del cancer; el metodo es la administracion a un sujeto de una cantidad reductora del efecto secundario de uno o mas inhibidores selectivos de ciclooxigenasa-2 (COX-2).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21268500P | 2000-06-20 | 2000-06-20 | |
PCT/US2001/019593 WO2001097806A1 (en) | 2000-06-20 | 2001-06-20 | Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02012879A true MXPA02012879A (es) | 2004-07-30 |
Family
ID=22792051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02012879A MXPA02012879A (es) | 2000-06-20 | 2001-06-20 | Inhibidores de ciclooxigenasa-2 y la prevencion de los efectos secundarios de terapia por radiacion. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20020035139A1 (es) |
EP (1) | EP1309328A4 (es) |
JP (1) | JP2003535896A (es) |
CN (1) | CN1437470A (es) |
AU (1) | AU2001271341A1 (es) |
CA (1) | CA2412362A1 (es) |
MX (1) | MXPA02012879A (es) |
WO (1) | WO2001097806A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20010733A1 (it) * | 2001-04-05 | 2002-10-05 | Recordati Chem Pharm | Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria |
EP2340034B2 (en) | 2008-08-07 | 2019-02-13 | The United States Of America, As Represented By The Secretary, Department of Health and Human Services | Radioprotectants targeting thrombospondin-1 and cd47 |
RU2690188C2 (ru) * | 2017-05-26 | 2019-05-31 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый мультитаргетный препарат для лечения заболеваний у млекопитающих |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5506145A (en) * | 1994-12-02 | 1996-04-09 | Bull; Brian S. | Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements |
JP4422796B2 (ja) * | 1995-07-21 | 2010-02-24 | タクティカル セラピューティクス インコーポレイテッド | アミノイミダゾールカルボキサミドおよび5−アミノ、または置換アミノ1,2,3−トリアゾールの塩による癌の治療および阻止 |
US6355656B1 (en) * | 1995-12-04 | 2002-03-12 | Celgene Corporation | Phenidate drug formulations having diminished abuse potential |
US6486177B2 (en) * | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
US6096728A (en) * | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
DK0942740T3 (da) * | 1996-12-06 | 2003-12-15 | Amgen Inc | Kombinationsterapi under anvendelse af et TFN-bindende protein til behandling af TFN-medierede sygdomme |
US5770217A (en) * | 1997-07-02 | 1998-06-23 | Atlatl, Inc. | Dietary supplement for hematological, immune and appetite enhancement |
US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
US6297015B1 (en) * | 1998-09-24 | 2001-10-02 | Ira Shafran | Crohn's disease diagnostic and treatment methods and compositions |
US6649645B1 (en) * | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
US20020009421A1 (en) * | 2000-06-01 | 2002-01-24 | Wilder Karol J. | Therapy following skin injury from exposure to ultraviolet radiation |
US6306842B1 (en) * | 2000-06-02 | 2001-10-23 | Medinox, Inc. | Protected forms of a combination of pharmacologically active agents and uses therefor |
-
2001
- 2001-06-20 EP EP01950340A patent/EP1309328A4/en not_active Withdrawn
- 2001-06-20 MX MXPA02012879A patent/MXPA02012879A/es unknown
- 2001-06-20 CA CA002412362A patent/CA2412362A1/en not_active Abandoned
- 2001-06-20 WO PCT/US2001/019593 patent/WO2001097806A1/en not_active Application Discontinuation
- 2001-06-20 CN CN01811513A patent/CN1437470A/zh active Pending
- 2001-06-20 US US09/884,466 patent/US20020035139A1/en not_active Abandoned
- 2001-06-20 AU AU2001271341A patent/AU2001271341A1/en not_active Abandoned
- 2001-06-20 JP JP2002503290A patent/JP2003535896A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2001097806A1 (en) | 2001-12-27 |
AU2001271341A1 (en) | 2002-01-02 |
EP1309328A1 (en) | 2003-05-14 |
JP2003535896A (ja) | 2003-12-02 |
EP1309328A4 (en) | 2006-02-08 |
CN1437470A (zh) | 2003-08-20 |
US20020035139A1 (en) | 2002-03-21 |
CA2412362A1 (en) | 2001-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL349216A1 (en) | Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia | |
IL156122A0 (en) | Geldanamycin derivative and method of treating cancer using same | |
TW200507833A (en) | Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents | |
PL349149A1 (en) | Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia | |
WO2005009342A3 (en) | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith | |
WO2002005791A3 (en) | Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor | |
WO2005000213A3 (en) | Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors | |
IL169702A0 (en) | Combination therapy of zd6474 with 5-fu or/and cpt-11 | |
WO2005000212A3 (en) | Method for treating diseases using hsp90-inhibiting agents in combination with nuclear export inhibitors | |
NZ504928A (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
Ogawa et al. | New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms | |
GB0308323D0 (en) | Electromagnetic stimulation in patients with osteoporosis | |
MXPA02012879A (es) | Inhibidores de ciclooxigenasa-2 y la prevencion de los efectos secundarios de terapia por radiacion. | |
NO984446L (no) | FremgangsmÕte for behandling av smerte | |
ATE338566T1 (de) | Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten | |
MX2023014778A (es) | Terapia de combinacion de radioinmunoconjugados e inhibidores de puntos de control. | |
DK0858341T3 (da) | Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin | |
WO2003079748A3 (en) | Potentiation of cancer therapies by znf217 inhibition | |
EP1146866A4 (en) | METHOD OF TREATMENT OF ACNEEPATIENTS BY ADMINISTERING CYCLIC GMP PDE INHIBITORS | |
DK1244442T3 (da) | Fremgangsmåde til bestemmelse af nukleotidsynteseinhibitorer med færre bivirkninger | |
UA40393A (uk) | Спосіб лікування хронічного обструктивного бронхіту | |
UA30769A (uk) | Спосіб лікування онкологічних захворювань | |
UA38322A (uk) | Спосіб лікування хронічного уретропростатиту та пристрій для його здійснення | |
UA30570A (uk) | Спосіб комплексного лікування пародонтиту | |
UA23971A (uk) | Спосіб комплексhого лікуваhhя хворих деструктивhим туберкульозом легеhь |